• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据长期 ANCA 模式评估抗中性粒细胞胞质抗体相关性血管炎的复发率和肾脏预后。

Relapse rate and renal prognosis in ANCA-associated vasculitis according to long-term ANCA patterns.

机构信息

Internal Medicine Service, Parc Tauli Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Catalonia, Spain.

Internal Medicine Service, Hospital Universitari Vall d'Hebrón, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.

出版信息

Clin Exp Immunol. 2021 Feb;203(2):209-218. doi: 10.1111/cei.13530. Epub 2020 Nov 2.

DOI:10.1111/cei.13530
PMID:33020895
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7806448/
Abstract

Long-term observation of patients with ANCA-associated vasculitis (AAV) allows the identification of different longitudinal patterns of ANCA levels during follow-up. This study aimed to characterize these patterns and to determine their prognostic significance. All ANCA determinations performed in two university hospitals during a 2-year period were retrospectively reviewed. Patients were included in the analysis if they had high titers of anti-myeloperoxidase (anti-MPO) or anti-proteinase 3 (anti-PR3) antibodies at least once, ≥ 5 serial ANCA determinations and AAV diagnosed by biopsy or American College of Rheumatology (ACR) classification criteria. Patients' time-course ANCA patterns were classified as monophasic, remitting, recurrent or persistent. Associations between ANCA patterns and prognostic variables (relapse rate and renal outcome) were analysed by univariate and multivariate statistics. A total of 99 patients [55 with microscopic polyangiitis (MPA), 36 with granulomatosis with polyangiitis (GPA) and eight with eosinophilic granulomatosis with polyangiitis (EGPA)] were included. Median follow-up was 9 years. Among patients diagnosed with MPA or GPA, recurrent or persistent ANCA patterns were associated with a higher risk of clinical relapse [hazard ratio (HR) = 3·7, 95% confidence interval (CI) = 1·5-9·1 and HR = 2·9, 95% CI = 1·1-8·0, respectively], independently of clinical diagnosis or ANCA specificity. In patients with anti-MPO antibodies, the recurrent ANCA pattern was associated with worsening renal function [odds ratio (OR) = 5·7, 95% CI = 1·2-26·0]. Recurrent or persistent ANCA patterns are associated with a higher risk of clinical relapse. A recurrent ANCA pattern was associated with worsening renal function in anti-MPO-associated vasculitis.

摘要

对抗中性粒细胞胞浆抗体(ANCA)相关性血管炎(AAV)患者进行长期观察,可识别出随访过程中 ANCA 水平的不同纵向模式。本研究旨在对这些模式进行特征描述,并确定其预后意义。回顾性分析了在两所大学医院进行的为期 2 年的所有 ANCA 检测。如果患者至少有一次抗髓过氧化物酶(抗-MPO)或抗蛋白酶 3(抗-PR3)抗体高滴度、≥5 次连续 ANCA 检测和经活检或美国风湿病学会(ACR)分类标准诊断的 AAV,则将其纳入分析。将患者的时间进程 ANCA 模式分为单相、缓解、复发或持续。通过单变量和多变量统计分析 ANCA 模式与预后变量(复发率和肾脏结局)之间的关联。共纳入 99 例患者[55 例显微镜下多血管炎(MPA)、36 例肉芽肿性多血管炎(GPA)和 8 例嗜酸性肉芽肿性多血管炎(EGPA)],中位随访时间为 9 年。在诊断为 MPA 或 GPA 的患者中,复发或持续的 ANCA 模式与更高的临床复发风险相关[风险比(HR)=3.7,95%置信区间(CI)=1.5-9.1 和 HR=2.9,95%CI=1.1-8.0],独立于临床诊断或 ANCA 特异性。在抗-MPO 抗体阳性的患者中,复发的 ANCA 模式与肾功能恶化相关[比值比(OR)=5.7,95%CI=1.2-26.0]。复发或持续的 ANCA 模式与更高的临床复发风险相关。复发的 ANCA 模式与抗-MPO 相关性血管炎的肾功能恶化相关。

相似文献

1
Relapse rate and renal prognosis in ANCA-associated vasculitis according to long-term ANCA patterns.根据长期 ANCA 模式评估抗中性粒细胞胞质抗体相关性血管炎的复发率和肾脏预后。
Clin Exp Immunol. 2021 Feb;203(2):209-218. doi: 10.1111/cei.13530. Epub 2020 Nov 2.
2
Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.韩国MPO-ANCA、PR3-ANCA及ANCA阴性血管炎患者的临床和预后特征
Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):111-118. Epub 2017 Mar 23.
3
The complexity of classifying ANCA-associated small-vessel vasculitis in actual clinical practice: data from a multicenter retrospective survey.在实际临床实践中对 ANCA 相关性小血管血管炎进行分类的复杂性:多中心回顾性调查数据。
Rheumatol Int. 2020 Feb;40(2):303-311. doi: 10.1007/s00296-019-04406-5. Epub 2019 Aug 5.
4
Seasonal Influence on Development of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Cohort Study Conducted at Multiple Institutions in Japan (J-CANVAS).季节对抗中性粒细胞胞质抗体相关性血管炎发展的影响:日本多机构回顾性队列研究(J-CANVAS)。
J Rheumatol. 2023 Sep;50(9):1152-1158. doi: 10.3899/jrheum.2023-0040. Epub 2023 Jun 1.
5
Antineutrophil cytoplasmic antibody-associated vasculitis classification by cluster analysis based on clinical phenotypes: a single-center retrospective cohort study.基于临床表型的聚类分析对中性粒细胞胞浆抗体相关性血管炎的分类:一项单中心回顾性队列研究。
Clin Rheumatol. 2024 Jan;43(1):367-376. doi: 10.1007/s10067-023-06720-7. Epub 2023 Aug 2.
6
Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification.根据抗体特异性对 ANCA 相关性血管炎进行亚组分类,超越临床病理分类的临床影响。
Rheumatology (Oxford). 2019 Oct 1;58(10):1731-1739. doi: 10.1093/rheumatology/kez016.
7
Immunopathogenesis of ANCA-Associated Vasculitis.抗中性粒细胞胞浆抗体相关性血管炎的免疫发病机制。
Int J Mol Sci. 2020 Oct 3;21(19):7319. doi: 10.3390/ijms21197319.
8
Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement.抗中性粒细胞胞浆抗体(ANCA)相关血管炎累及肾脏时临床、血清学及组织病理学分类方案的临床表现及预后预测
Clin Rheumatol. 2016 Jul;35(7):1805-16. doi: 10.1007/s10067-016-3195-z. Epub 2016 Feb 6.
9
Significance of clinical-immunological patterns and diagnostic yield of biopsies in microscopic polyangiitis and granulomatosis with polyangiitis.显微镜下多血管炎和肉芽肿性多血管炎的临床免疫模式及活检的诊断价值。
J Intern Med. 2024 May;295(5):651-667. doi: 10.1111/joim.13777. Epub 2024 Mar 11.
10
Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management.抗中性粒细胞胞质抗体相关性血管炎的遗传学:在发病机制、分类和管理中的作用。
Nat Rev Rheumatol. 2022 Oct;18(10):559-574. doi: 10.1038/s41584-022-00819-y. Epub 2022 Sep 15.

引用本文的文献

1
Antineutrophil Cytoplasmic Antibodies (ANCAs): Role in Diagnosis, Disease Monitoring, and Prognosis.抗中性粒细胞胞浆抗体(ANCA):在诊断、疾病监测及预后中的作用
J Am Soc Nephrol. 2025 May 7;36(7):1428-38. doi: 10.1681/ASN.0000000749.
2
[Diagnosis and treatment of ANCA-associated vasculitis : S3 guideline of the German Society for Rheumatology and Clinical Immunology e. V. (DGRh) and German Society for Internal Medicine e. V. (DGIM), German Society for Nephrology e. V. (DGfN), German Society for ENT Medicine and Head and Neck Surgery e. V. (DGHNO-KHC), German Ophthalmological Society e. V. (DOG), German Society for Neurology e. V. (DGN), German Society for Pneumology and Respiratory Medicine e. V. (DGP), German Society for Pathology e. V. (DGP), German Radiological Society, Society for Medical Radiology e. V. (DRG), Federal Association of German Pathologists, Federal Kidney Association e. V., German Rheumatism League Federal Association e. V.].抗中性粒细胞胞浆抗体相关血管炎的诊断与治疗:德国风湿病学会和临床免疫学协会(DGRh)、德国内科医学协会(DGIM)、德国肾脏病学会(DGfN)、德国耳鼻喉科与头颈外科学会(DGHNO-KHC)、德国眼科学会(DOG)、德国神经病学会(DGN)、德国肺病与呼吸医学学会(DGP)、德国病理学会(DGP)、德国放射学会、医学放射学会(DRG)、德国病理学家联邦协会、联邦肾脏协会、德国风湿病联盟联邦协会联合发布的S3指南
Z Rheumatol. 2025 Apr;84(Suppl 1):1-49. doi: 10.1007/s00393-024-01597-6. Epub 2025 Apr 3.
3
How We Treat ANCA-Associated Vasculitis: A Focus on the Maintenance Therapy.我们如何治疗抗中性粒细胞胞浆抗体相关性血管炎:聚焦维持治疗
J Clin Med. 2025 Jan 2;14(1):208. doi: 10.3390/jcm14010208.
4
An update on risk factors for relapse in antineutrophil cytoplasmic antibody-associated vasculitis.抗中性粒细胞胞质抗体相关性血管炎复发危险因素的最新研究进展。
Clin Exp Immunol. 2024 Oct 16;218(2):120-135. doi: 10.1093/cei/uxae068.
5
Adding 6-month parameters for the prediction of kidney prognosis in ANCA-associated glomerulonephritis.添加6个月参数用于预测抗中性粒细胞胞浆抗体相关性肾小球肾炎的肾脏预后。
Clin Kidney J. 2023 Jul 4;16(12):2530-2541. doi: 10.1093/ckj/sfad157. eCollection 2023 Dec.
6
Ocular and orbital manifestations of granulomatosis with polyangiitis: a systematic review of published cases.肉芽肿性多血管炎的眼部和眼眶表现:已发表病例的系统回顾。
Rom J Ophthalmol. 2023 Jul-Sep;67(3):214-221. doi: 10.22336/rjo.2023.38.
7
Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): Part 2 - Treatment of eosinophilic granulomatosis with polyangiitis and diagnosis and general management of AAV.系统文献回顾为 2022 年更新 EULAR 关于抗中性粒细胞胞浆抗体相关性血管炎(AAV)管理的建议提供信息:第 2 部分 - 嗜酸性肉芽肿性多血管炎的治疗和 AAV 的诊断与一般管理。
RMD Open. 2023 Jun;9(2). doi: 10.1136/rmdopen-2023-003083.
8
Neutrophils in ANCA-associated vasculitis: Mechanisms and implications for management.抗中性粒细胞胞浆抗体相关血管炎中的中性粒细胞:作用机制及对治疗的意义
Front Pharmacol. 2022 Sep 23;13:957660. doi: 10.3389/fphar.2022.957660. eCollection 2022.
9
The association of 5-year therapeutic responsiveness with long-term renal outcome in IgA nephropathy.IgA 肾病中 5 年治疗反应与长期肾脏结局的关联。
Clin Exp Nephrol. 2022 Aug;26(8):797-807. doi: 10.1007/s10157-022-02221-0. Epub 2022 Apr 15.
10
Anti-neutrophil cytoplasmic antibody-associated vasculitis complicated with diffuse alveolar haemorrhage and central nervous system vasculitis.抗中性粒细胞胞浆抗体相关性血管炎合并弥漫性肺泡出血和中枢神经系统血管炎。
SAGE Open Med Case Rep. 2021 Apr 27;9:2050313X211011814. doi: 10.1177/2050313X211011814. eCollection 2021.

本文引用的文献

1
The Diagnostic and Clinical Utility of Autoantibodies in Systemic Vasculitis.自身抗体在系统性血管炎中的诊断及临床应用价值
Antibodies (Basel). 2019 May 1;8(2):31. doi: 10.3390/antib8020031.
2
Determinants of renal and patient outcomes in a Spanish cohort of patients with ANCA-associated vasculitis and renal involvement.在西班牙 ANCAs 相关性血管炎伴肾损害患者队列中,影响肾脏和患者结局的因素。
Clin Rheumatol. 2018 Apr;37(4):1065-1074. doi: 10.1007/s10067-017-3973-2. Epub 2018 Mar 9.
3
Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis.立场文件:2017 年关于肉芽肿性多血管炎和显微镜下多血管炎抗中性粒细胞胞浆抗体检测的国际共识修订版。
Nat Rev Rheumatol. 2017 Nov;13(11):683-692. doi: 10.1038/nrrheum.2017.140. Epub 2017 Sep 14.
4
ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients.抗中性粒细胞胞质抗体相关性血管炎 - 使用抗中性粒细胞胞质抗体特异性对患者进行分类的临床应用。
Nat Rev Rheumatol. 2016 Oct;12(10):570-9. doi: 10.1038/nrrheum.2016.123. Epub 2016 Jul 28.
5
Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3.影响抗中性粒细胞胞浆抗体(针对蛋白酶 3)连续检测临床效用的因素。
Arthritis Rheumatol. 2016 Jul;68(7):1700-10. doi: 10.1002/art.39637.
6
Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study.日本显微镜下多血管炎和肉芽肿性多血管炎患者中不同分类疾病及严重程度对治疗的反应:一项全国性前瞻性起始队列研究。
Arthritis Res Ther. 2015 Nov 2;17:305. doi: 10.1186/s13075-015-0815-y.
7
There is no benefit in routinely monitoring ANCA titres in patients with granulomatosis with polyangiitis.对于患有肉芽肿性多血管炎的患者,常规监测抗中性粒细胞胞浆抗体(ANCA)滴度并无益处。
Clin Exp Rheumatol. 2015 Mar-Apr;33(2 Suppl 89):S-72-6. Epub 2015 May 26.
8
Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature.抗中性粒细胞胞浆抗体(ANCA)相关血管炎中的肺纤维化:49例患者系列研究及文献综述
Medicine (Baltimore). 2014 Nov;93(24):340-349. doi: 10.1097/MD.0000000000000217.
9
ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease.抗中性粒细胞胞浆抗体作为复发的预测指标:对有肾脏受累的患者有用,但对无肾脏疾病的患者无用。
J Am Soc Nephrol. 2015 Mar;26(3):537-42. doi: 10.1681/ASN.2013111233. Epub 2014 Oct 16.
10
Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors.抗中性粒细胞胞浆抗体相关性肾小球肾炎的长期预后:国际组织学分类及其他预后因素评估
Nephrol Dial Transplant. 2015 Jul;30(7):1185-92. doi: 10.1093/ndt/gfu237. Epub 2014 Jul 12.